Skip to main content
Daniel Bertges, MD, Vascular Surgery, Burlington, VT, Northwestern Medical Center

DanielJosephBertgesMD

Vascular Surgery Burlington, VT

Associate Professor, Surgery, University of Vermont College of Medicine

Dr. Bertges is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Bertges' full profile

Already have an account?

  • Office

    111 Colchester Avenue
    Main Campus, Main Pavilion, Level 5
    Burlington, VT 05401
    Phone+1 802-847-4548
    Fax+1 802-847-0970
  • Is this information wrong?

Education & Training

  • UPMC Medical Education
    UPMC Medical EducationFellowship, Vascular Surgery, 2001 - 2003
  • UPMC Medical Education (Pittsburgh)
    UPMC Medical Education (Pittsburgh)Residency, Surgery, 1999 - 2001
  • UPMC Medical Education (Pittsburgh)
    UPMC Medical Education (Pittsburgh)Residency, Surgery, 1994 - 1996
  • University of Pittsburgh School of Medicine
    University of Pittsburgh School of MedicineClass of 1994

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2006 - 2025
  • VT State Medical License
    VT State Medical License 2003 - 2024
  • PA State Medical License
    PA State Medical License 1995 - 2004
  • American Board of Surgery Vascular Surgery

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Fellow (FACS) American College of Surgeons

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • NESVS12. Analysis of 30-Day Readmission After Infrainguinal Bypass: Lessons Learned from a Trial of 30-Day Data Collection in the Vascular Study Group of New England  
    Eric G Bluemn, Francesco A Aiello, Daniel J Bertges, Alik Farber, Philip P Goodney, Andres Schanzer, Jessica P Simons, Journal of Vascular Surgery
  • Nationwide Trends in Drug-Coated Balloon and Drug-Eluting Stent Utilization in the Femoropopliteal Arteries  
    Abhisekh Mohapatra, Daniel J Bertges, Michael C Madigan, Georges E Al-Khoury, Mohammad H Eslami, Journal of Vascular Surgery
  • The Impact of Perioperative Ankle-Brachial Index and Clinical Status on Outcomes Following Lower Extremity Bypass  
    Marc L Schermerhorn, Jeffrey J Siracuse, Daniel J Bertges, Alik Farber, Annals of Vascular Surgery

Lectures

  • Registry Assessment of Peripheral Interventional Devices (RAPID) ― Registry Assessment of Peripheral Interventional Devices Core Data Elements ― 
    University of Vermont College of Medicine, Stowe, Vermont - 1/30/2012

Authored Content

  • Registry Assessment of Peripheral Interventional Devices (RAPID) ― Registry Assessment of Peripheral Interventional Devices Core Data Elements ―February 2019
  • Registry Assessment of Peripheral Interventional Devices (RAPID) ― Registry Assessment of Peripheral Interventional Devices Core Data Elements ―February 2019
  • Registry Assessment of Peripheral Interventional Devices (RAPID) ― Registry Assessment of Peripheral Interventional Devices Core Data Elements ―February 2019
  • Registry Assessment of Peripheral Interventional Devices (RAPID) ― Registry Assessment of Peripheral Interventional Devices Core Data Elements ―February 2019
  • NESVS12. Analysis of 30-Day Readmission After Infrainguinal Bypass: Lessons Learned from a Trial of 30-Day Data Collection in the Vascular Study Group of New EnglandSeptember 2018
  • Peripheral Vascular Stent Infection: Case Report and Review of LiteratureMay 2018
  • Predictors of Myocardial Infarction After Suprainguinal Bypass Using the Vascular Quality Initiative Cardiac Risk IndexMarch 2018
  • Join now to see all

Press Mentions

  • Drug-Coated Balloons an Effective Tool in the Battle Against Femoropopliteal Disease
    Drug-Coated Balloons an Effective Tool in the Battle Against Femoropopliteal DiseaseNovember 4th, 2022
  • Late-Breaking Clinical Trial Presentations Announced for the VEINS and VIVA Conference
    Late-Breaking Clinical Trial Presentations Announced for the VEINS and VIVA ConferenceSeptember 14th, 2022

Professional Memberships

Hospital Affiliations